+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Recalbon"

Recalbon- Drug Insight, 2019 - Product Thumbnail Image

Recalbon- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Recalbon market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat conditions such as diabetes, obesity, and thyroid disorders. These drugs are used to regulate hormones and metabolism, and can be administered orally, intravenously, or through injections. Recalbon drugs are typically prescribed to treat chronic conditions, and are often used in combination with lifestyle changes such as diet and exercise. The Recalbon market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Other companies such as AstraZeneca, Boehringer Ingelheim, and Takeda also offer Recalbon drugs. Show Less Read more